EXPEREO
14.7.2022 03:02:12 CEST | Business Wire | Press release
Expereo , the leading provider of managed Internet, Cloud Access Optimization, SASE, and SD-WAN solutions, is pleased to announce the appointments of Daniel Beevers as Managing Director EMEA and Eric Wong as Regional Director Asia Pacific as the company accelerates its growth, scaling its leadership in support of global customer base.
Beevers and Wong will lead and grow enterprise business, while driving exceptional customer experience, within their respective geographies. Both leaders are major hires for Expereo as it continues its global expansion and development, due to their strong industry experience, exceptional enterprise customer experience track records, and depth of international knowledge serving multi-national organizations.
They join Ben Elms, Chief Revenue Officer who was appointed earlier this year to accelerate growth of the company, leading Sales and go-to-market transformation across all channels driving the expansion and adoption of Expereo’s services globally.
“Asia Pacific is a key growth area for Expereo, and Eric will be instrumental in driving our ambitions for the region. We are pleased to welcome Eric as an important member of our team, supporting our customers with their digital transformation across APAC,” says Expereo’s Chief Executive Officer, Irwin Fouwels. “The addition of Dan, helps us also to focus on our core EMEA market and continue to provide solutions that ensure a smooth transition for companies looking to power-up their network capabilities and enhance global productivity. These new, but vastly experienced members of our leadership team will help us expand the global footprint and more importantly, better positions us to best meet our customers’ needs.”
Dan Beevers joins Expereo’s leadership team with more than 20 years of experience in the telecommunications industry. Leveraging his experience in executive roles throughout Europe, Asia and Australia, Beevers will have a keen focus on developing world-class sales teams and driving enterprise sales across EMEA markets.
“I’m excited to join Expereo at this transformative time and help to build on an already solid foundation,” said Dan Beevers, Managing Director, EMEA. “Expereo is perfectly positioned to help clients digitally transform their business and compete in the modern, digital marketplace.”
Eric Wong will also draw from his 20 years of industry experience with many of the world’s largest multi-national companies to provide innovative and customer-centric solutions for Expereo’s Asia Pacific clients.
“I’m thrilled to be joining the Expereo family and to lead the next phase of growth. The digitalization megatrends across the region present an abundance of opportunities for Expereo to enable enterprises to take advantage of the connected age,” said Eric Wong, Regional Director of Asia Pacific.
Expereo continues its global growth and development by investing in regional markets. The opening of offices in the Philippines this month and Germany in August, brings the business closer to customers and further delivers on regional knowledge, providing a superior local experience around the world, delivering simplified global networks while delighting customers with seamless connectivity services from a single, trusted provider.
About Expereo
Expereo is a leading global provider of managed network solutions including, Global Internet, SD-WAN/SASE, and Enhanced Internet. With an extensive global reach, Expereo is the trusted partner of 30% of Fortune 500 companies. It powers enterprise and government sites in more than 190 countries, helping customers improve productivity and empowering their networks and cloud services with the agility, flexibility and value of the Internet, with optimal network performance.
Expereo was acquired in February 2021, by Vitruvian Partners. The international growth capital and buyout firm acquired a majority shareholding from leading European private equity firm, Apax Partners sas.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220713005752/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom